Related Experiment Video
Updated: Feb 6, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
BRCAness and prostate cancer: diagnostic and therapeutic considerations
Mallika Dhawan1, Charles J Ryan2
1Genitourinary Medical Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, 94115, USA.
Background:
Recent advances in genetic sequencing and recent studies focusing on the broader use of Poly ADP Ribose polymerase (PARP) inhibitors have led to an upsurge of interest in DNA repair mutations as they relate to prostate cancer.
Methods:
This review outlines ongoing studies and recent publications as they relate to the prevalence and detection of DNA repair mutations in metastatic prostate cancer. The detection of these mutations through multiple diagnostic approaches is discussed, including germline sequencing, somatic sequencing, cell-free DNA assays, and circulating tumor cell assays. The clinical course of patients with prostate cancer and DNA repair gene mutations is explored in addition to therapeutic strategies for this population.
Conclusions:
In men with metastatic prostate cancer, it is reasonable to obtain germline genetic sequencing as well as somatic tumor genomic sequencing to help guide further treatment decisions that may include PARP inhibitors or carboplatin in the future. In the future, in men with metastatic castrate resistant prostate cancer with progression on PARP inhibitors, cell-free DNA sequencing may help elucidate mechanisms of resistance, which include reversion mutations.
Insights
Genetic sequencing can identify DNA repair mutations in metastatic prostate cancer. This information guides treatment decisions, potentially including Poly ADP Ribose polymerase (PARP) inhibitors and other therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Advances in genetic sequencing and Poly ADP Ribose polymerase (PARP) inhibitors have increased interest in DNA repair mutations in prostate cancer.
- Prostate cancer research is increasingly focused on the role of DNA repair deficiencies.
Purpose of the Study:
- To review the prevalence and detection of DNA repair mutations in metastatic prostate cancer.
- To explore the clinical course and therapeutic strategies for patients with these mutations.
Main Methods:
- Review of ongoing studies and recent publications.
- Discussion of diagnostic approaches including germline and somatic sequencing, cell-free DNA assays, and circulating tumor cell assays.
Main Results:
- Identification of DNA repair mutations is crucial for treatment decisions in metastatic prostate cancer.
- Multiple diagnostic methods are available for detecting these mutations.
Conclusions:
- Germline and somatic sequencing are recommended for men with metastatic prostate cancer to guide treatment with agents like PARP inhibitors or carboplatin.
- Cell-free DNA sequencing may reveal resistance mechanisms in advanced prostate cancer treated with PARP inhibitors.
Related Concept Videos
Design Consideration
The factor of safety is another key...
Tensile Strength Considerations of Concrete
The dimensions and shape of a concrete specimen...
Transmission Line Design Considerations
Therapeutic Index
Special considerations while measuring pulse
Energy Considerations in Open Channel Flow

